The jada failed to stop bleeding [device ineffective].Case narrative: this spontaneous report originating from united states was received from a facility clinical educator (ce) via clinical account specialist (cas), referring to a female patient of unknown age.The patient's medical history, concurrent conditions, concomitant medications, and drug reactions/allergies were not reported.This report concerned 1 patient and 1 device.On unknown date approximately in (b)(6) 2023 (reported as last week (specific date unknown), the patient had placement with vacuum-induced hemorrhage control system (jada system) (lot# and expiration date were not reported) to stop bleeding, but the vacuum-induced hemorrhage control system (jada system) failed to stop bleeding (device ineffective).Clinical account specialist (cas) had very limited information and had attempted to gather further information however the facility clinical educator (ce) refused to inform and also refused to let the clinical account specialist (cas) back into the facility to do any further training.Clinical educator stated that they do not need any further assistance, as they were fine.No further information provided, no additional adverse event (ae) reported, no product quality complaint (pqc) reported.For vacuum-induced hemorrhage control system (jada system), the lot number and the serial number were not available.Upon internal review, the event device ineffective was considered to be medically significant.Medical device reporting criteria: serious injury.When the lot number is unknown, a technical investigation of the specific manufacturing process which includes review of records associated with a known lot number cannot be performed.Therefore, priority quality investigation will not be completed.Fda code: (health effects - health impact per annex f): 4648 insufficient information (there is not yet enough information available to classify the health impact).This is one of the two reports received from the same reporter.
|